Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.52 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.52 |
| ▸ | FAAH | O00519 | 2/20 | 0.49 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.48 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.47 |
| ▸ | S1PR4 | O95977 | 5/20 | 0.47 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.47 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.47 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19066838 | 0.98 | ALDH1A1 (0.59) | TSHRALDH1A1FFAR4FFAR1FAAH | |
| SCHEMBL19066837 | 0.98 | ALDH1A1 (0.59) | TSHRALDH1A1FFAR4FFAR1FAAH | |
| SCHEMBL1289280 | 0.98 | ALDH1A1 (0.59) | TSHRALDH1A1FFAR4FFAR1FAAH | |
| SCHEMBL9880954 | 0.98 | ALDH1A1 (0.59) | TSHRALDH1A1FFAR4FFAR1FAAH | |
| SCHEMBL748528 | 0.96 | ALDH1A1 (0.56) | TSHRALDH1A1FFAR4FFAR1FAAH | |
| SCHEMBL27828680 | 0.96 | FFAR4 (0.52) | TSHRALDH1A1FFAR4FFAR1FAAH | |
| SCHEMBL7086817 | 0.96 | ALDH1A1 (0.56) | TSHRALDH1A1FFAR4FFAR1FAAH | |
| Ethylene SCHEMBL11903760 | 0.94 | ALDH1A1 (0.54) | TSHRALDH1A1FFAR4FFAR1FAAH | |
| SCHEMBL29894248 | 0.94 | ALDH1A1 (0.54) | TSHRALDH1A1FFAR4FFAR1FAAH | |
| SCHEMBL1687579 | 0.94 | ALDH1A1 (0.54) | TSHRALDH1A1FFAR4FFAR1FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9708521-B2 | Systems and methods employing low molecular weight gelators for crude oil, petroleum product or chemical spill containment and remediation | GEORGETOWN UNIVERSITY (US) | 2017-07-18 | — | — | US | disclosed |
| US-9109150-B2 | Fast recovery of thixotropy by organogels with low molecular weight gelators | GEORGETOWN UNIVERSITY (US) | 2015-08-18 | — | — | US | disclosed |
| EP-2609066-A1 | LOW MOLECULAR WEIGHT GELATORS FOR CRUDE OIL, PETROLEUM PRODUCT OR CHEMICAL SPILL CONTAINMENT | Georgetown University (US) | 2013-07-03 | — | — | EP | disclosed |
| US-20120136074-A1 | SYSTEMS AND METHODS EMPLOYING LOW MOLECULAR WEIGHT GELATORS FOR CRUDE OIL, PETROLEUM PRODUCT OR CHEMICAL SPILL CONTAINMENT AND REMEDIATION | GEORGETOWN UNIVERSITY (US) | 2012-05-31 | — | — | US | disclosed |
| WO-2012047251-A1 | LOW MOLECULAR WEIGHT GELATORS FOR CRUDE OIL, PETROLEUM PRODUCT OR CHEMICAL SPILL CONTAINMENT | GEORGETOWN UNIVERSITY (US) | 2012-04-12 | — | — | WO | disclosed |
| US-20110251294-A1 | FAST RECOVERY OF THIXOTROPY BY ORGANOGELS WITH LOW MOLECULAR WEIGHT GELATORS | GEORGETOWN UNIVERSITY (US) | 2011-10-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110251294-A1 | FAST RECOVERY OF THIXOTROPY BY ORGANOGELS WITH LOW MOLECULAR WEIGHT GELATORS | TBXAS1, TBXA2R, TSNAX | TSHR 51/4885ALDH1A1 1454/4885FFAR4 1409/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.